Jonathan P. Northrup is listed as an executive officer, director, and promoter on 16 SEC Form D filings by 5 issuers between Jan 2011 and May 2024: Stingray Therapeutics, Inc. (Dallas, TX — biotechnology — 2020–2024; $6.61M reported sold to 52 investors), Beta Cat Pharmaceuticals, Inc. (Houston, TX — pharmaceuticals — 2014–2018; $2.6M reported sold to 17 investors), ConverGene LLC (Gaithersburg, MD — biotechnology — 2014; $850K reported sold to 9 investors), Salarius Pharmaceuticals, LLC (Holladay, UT — pharmaceuticals — 2016; $775K reported sold to 8 investors) and Beta Cat Pharmaceuticals, LLC (Greenwood, IN — biotechnology — 2011; $275K reported sold to 7 investors).
What this means A repeat sponsor — 5 separate companies raised money with this person listed as executive officer, director, and promoter, over about 13 years. Across those companies the filings report $11.1M sold in total.
Listed alongside Sunil Sharma (15 shared filings), Uma Bhatt (5 shared filings), Kenneth Carter (4 shared filings), Scott Andrew Jordan (4 shared filings), Alain Cappeluti (3 shared filings) and 11 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Jonathan. Each name links to their own page.
The issuers belong to 2 sponsor groups: Beta Cat Pharmaceuticals (2 issuers, $2.88M reported sold, 2011–2018) and Noble (2 issuers, $1.08M reported sold, 2012–2014).
What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 2 bankruptcy cases matching the name listed in Key records below.
What this means 2 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 16 public filings for Jonathan P. Northrup and found 14 differences, 2 worth asking the sponsor about: Paid seller listed without a CRD number: Liberi Life Sciences Consultancy BV; 8 Form Ds were filed more than 15 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.